Loading…
GlucoTrack, Inc. is projected to decline to $0.4103 by 2027, a -2% move from its current price of $0.4174. GCTK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.3916 | $0.4173 | $0.4446 | -0.04% |
| Jul 13 | $0.3813 | $0.4171 | $0.4563 | -0.07% |
| Jul 14 | $0.3735 | $0.417 | $0.4654 | -0.11% |
| Jul 15 | $0.3671 | $0.4168 | $0.4732 | -0.14% |
| Jul 16 | $0.3615 | $0.4167 | $0.4802 | -0.18% |
| Jul 17 | $0.3565 | $0.4165 | $0.4866 | -0.21% |
| Jul 18 | $0.352 | $0.4164 | $0.4925 | -0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.352 | $0.4164 | $0.4925 | -0.25% |
| Week 2 | $0.3275 | $0.4153 | $0.5266 | -0.50% |
| Week 3 | $0.3097 | $0.4143 | $0.5541 | -0.75% |
| Week 4 | $0.2954 | $0.4132 | $0.5781 | -1.00% |
| Week 5 | $0.2832 | $0.4122 | $0.60 | -1.25% |
| Week 6 | $0.2725 | $0.4112 | $0.6203 | -1.50% |
| Week 7 | $0.263 | $0.4101 | $0.6395 | -1.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GlucoTrack, Inc. is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The GlucoTrack CBGM is a long-term implantable blood-based CBGM intended for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
GlucoTrack, Inc. (GCTK) is the asset with a current price of $0.4174 and a market cap of $2.61M. It is ranked 5393 by market capitalization. The current price point sits within a high-variance, low-price niche as reflected by its volatility metrics.
The 30-day technical picture shows a neutral posture with RSI at 50, a SMA50 of $0.5407, and a SMA200 of $2.94. Support is at $0.312 and resistance at $0.665, with a 30-day price range from $0.2747 to $0.6342. The annualized volatility stands at 100%, underscoring notable near-term fluctuation around the current level.
A major floor 73.2% below — a decisive break under it would weaken the trend.
The nearest floor, 25.3% below — buyers have tended to step in here.
The nearest ceiling, 59.3% above — a clean break opens room to run.
A major ceiling 261.8% above — clearing it would confirm fresh momentum.
Key GCTK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GCTK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.37 | Buy | $0.3797 | Buy |
| MA 10 | $0.3479 | Buy | $0.3682 | Buy |
| MA 20 | $0.3619 | Buy | $0.3931 | Buy |
| MA 50 | $0.5407 | Sell | $0.5691 | Sell |
| MA 100 | $0.8193 | Sell | $1.91 | Sell |
| MA 200 | $2.94 | Sell | $45.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.03 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 136.50 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 14.56 | Buy |
| Bollinger %B (20,2) | 0.93 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -2.01 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 67.86 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 0.40 | Buy |
| ADX (14) | 29.03 | Sell |
| ATR (14) | 0.02 | Info |
Near-term sentiment and key levels suggest a cautious stance. The overall sentiment is NEUTRAL, with RSI at 50 indicating a balanced momentum around the midpoint. Key moving averages show the SMA50 at $0.5407 and the SMA200 at $2.94, placing the recent price closer to the shorter-term average.
Support sits at $0.312 and resistance at $0.665. The 30-day price range spans from $0.2747 to $0.6342, highlighting a modestly volatile short window around the current price of $0.4174.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.312 | $0.4174 | $0.6032 | 0% | Neutral | |
| $0.2976 | $0.4103 | $0.6115 | -2% | Neutral | |
| $0.3665 | $0.5369 | $0.8528 | +29% | Bullish | |
| $0.3956 | $0.6104 | $1.02 | +46% | Bullish | |
| $0.3969 | $0.6421 | $1.11 | +54% | Bullish | |
| $0.3802 | $0.6428 | $1.15 | +54% | Bullish | |
| $0.3097 | $0.5462 | $1.01 | +31% | Bullish | |
| $0.2758 | $0.5065 | $0.9645 | +21% | Bullish | |
| $0.2812 | $0.5372 | $1.05 | +29% | Bullish | |
| $0.373 | $0.7407 | $1.48 | +77% | Bullish | |
| $0.2904 | $0.6453 | $1.42 | +55% | Bullish | |
| $0.7913 | $1.76 | $4.04 | +321% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.312 | $0.4174 | $0.5032 | +0.00% |
| August 2026 | $0.3507 | $0.4249 | $0.5364 | +1.80% |
| September 2026 | $0.3287 | $0.404 | $0.5206 | -4.93% |
| October 2026 | $0.3043 | $0.3786 | $0.4964 | -6.28% |
| November 2026 | $0.3272 | $0.4112 | $0.5469 | +8.62% |
| December 2026 | $0.3527 | $0.4476 | $0.6032 | +8.85% |
Click any year to see its month-by-month GCTK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GCTK could reach as high as $0.6032, with a base case around $0.4174 and support toward $0.312 — roughly 0% from $0.4174. Price action looks broadly range-bound.
Expect GCTK to range from $0.2976 to $0.6115 through 2027. The $0.4103 average target implies a -2% move from current prices. That is -2% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The GCTK price prediction for 2028 points to an average of $0.5369 (low $0.3665, high $0.8528) — a potential gain of +29% on today's $0.4174. Momentum favours further upside here.
In 2029, GCTK is projected to trade between $0.3956 and $1.02, averaging $0.6104 — a potential gain of +46% from today's $0.4174. That is up +14% on the projected 2028 average. Buyers look set to stay in control over this stretch.
GlucoTrack, Inc.'s 2030 outlook centres on $0.6421, within a $0.3969 to $1.11 range. That is up +5% on the projected 2029 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2031, GCTK could reach as high as $1.15, with a base case around $0.6428 and support toward $0.3802 — roughly +54% from $0.4174. Buyers look set to stay in control over this stretch.
Expect GCTK to range from $0.3097 to $1.01 through 2032. The $0.5462 average target implies a +31% move from current prices. That is -15% versus the projected 2031 average. Momentum favours further upside here.
The GCTK price prediction for 2033 points to an average of $0.5065 (low $0.2758, high $0.9645) — a potential gain of +21% on today's $0.4174. Buyers look set to stay in control over this stretch.
In 2034, GCTK is projected to trade between $0.2812 and $1.05, averaging $0.5372 — a potential gain of +29% from today's $0.4174. That is up +6% on the projected 2033 average. Momentum favours further upside here.
GlucoTrack, Inc.'s 2035 outlook centres on $0.7407, within a $0.373 to $1.48 range. That is up +38% on the projected 2034 average. That marks a +77% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, GCTK could reach as high as $1.42, with a base case around $0.6453 and support toward $0.2904 — roughly +55% from $0.4174. Momentum favours further upside here.
Expect GCTK to range from $0.7913 to $4.04 through 2050. The $1.76 average target implies a +321% move from current prices. That is up +173% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GCTK today (≈ 2,395.783421 GCTK) could be worth
$4,212.96
+$3,212.96 (+321%) by 2050 · US Dollar
Based on the average projected GCTK price of $1.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GCTKwould be worth at today's price.
$1,000 invested in GCTK on Jul 10, 2025 (≈ 170.940174 GCTK) would be worth
$71.35
-$928.65 (-92.9%) today · 0.07× · US Dollar
Based on a GCTK entry price of $5.85 vs. today's $0.4174.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.32 | $1,304.38 | +30.4% |
| 1 month ago | $0.401 | $1,040.9 | +4.1% |
| 3 months ago | $0.665 | $627.67 | -37.2% |
| 6 months ago | $3.82 | $109.27 | -89.1% |
| 1 year ago | $5.85 | $71.35 | -92.9% |
| All time (5.0y) ago | $31,980 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GCTK forecast.
Our base-case forecast reaches $0.83 around 2050.
Implied market cap at $0.83: $5.2M
The multi-year forecast paints a bullish trajectory after a period of neutrality, with year-by-year averages rising and strong upside potential by 2050. In 2026 the average is $0.4174 with a min of $0.312 and a max of $0.6032 (RO I 0%). The forecast grows into 2028 with an average of $0.5369 and remains bullish thereafter, reaching an average of $0.6421 in 2030 and $0.6428 in 2031, with max values climbing to $1.11 and $1.15 respectively and modest but positive ROIs (e.g., 53.8% in 2030, 54% in 2031).
The long-term outlook extends to 2040 with an average of $0.6453 and a 54.6% ROI, and culminates in 2050 with an average of $1.76 and a max of $4.04, representing a 321.3% ROI and a bullish sentiment. These figures reflect an ascending price path over time, with substantial upside by mid-century. While the numbers show meaningful upside, they are estimates and not guarantees, and actual results can differ due to market conditions and other risks.
Tap a question to reveal the answer.
For 2030, the forecast shows a min of $0.3969, an average of $0.6421, and a max of $1.11, with a projected ROI of 53.8% and a bullish sentiment.
The forecast turns bullish in the later years, with 2028 having an average of $0.5369 and 2030 at $0.6421 on average, and a 2050 average of $1.76 with a max of $4.04 and a 321.3% ROI. Earlier years show neutral sentiment, and these are estimates, not guarantees.
Yes. The 2029 forecast max is $1.02 and the 2030 forecast max is $1.11, indicating the possibility of surpassing $1.00 within the forecast window.
Current price is $0.4174 and market cap is $2.61M.
The 30-day technical picture is NEUTRAL with RSI(14) at 50, SMA50 at $0.5407, SMA200 at $2.94, support at $0.312, resistance at $0.665, and a 30-day range of $0.2747 to $0.6342.
GlucoTrack, Inc. Community Discussion
0Share your GlucoTrack, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.